Goldberg Andrew D. has filed 15 insider transactions across 1 company since June 2023.
Most recent transaction: a option exercise of 3350 shares of Tarsus Pharmaceuticals, Inc. ($TARS) on June 13, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 13, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | M | Common Stock | 3350 | $0.00 | 16,700.0000 | 37,604,538 | 25.09% | 0.01% |
| June 12, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | A | Stock Option (right to buy) | 4540 | $0.00 | 4,540.0000 | 37,604,538 | 9999.99% | 0.01% |
| June 12, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | A | Restricted Stock Units | 2954 | $0.00 | 2,954.0000 | 37,604,538 | 9999.99% | 0.01% |
| June 13, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | M | Restricted Stock Units | 3350 | $0.00 | 0.0000 | 37,604,538 | 100.00% | 0.01% |
| March 7, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | M | Common Stock | 7000 | $12.89 | 13,350.0000 | 37,604,538 | 110.24% | 0.02% |
| March 7, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | M | Stock Option (right to buy) | 7000 | $0.00 | 0.0000 | 37,604,538 | 100.00% | 0.02% |
| June 24, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | M | Common Stock | 3350 | $0.00 | 6,350.0000 | 29,383,276 | 111.67% | 0.01% |
| June 24, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | M | Restricted Stock Units | 3350 | $0.00 | 0.0000 | 29,383,276 | 100.00% | 0.01% |
| June 13, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 29,383,276 | 9999.99% | 0.02% |
| June 13, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | A | Restricted Stock Units | 3350 | $0.00 | 3,350.0000 | 29,383,276 | 9999.99% | 0.01% |
| Dec. 15, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | P | Common Stock | 1000 | $18.96 | 3,000.0000 | 24,619,700 | 50.00% | 0.00% |
| June 22, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 24,619,700 | 9999.99% | 0.02% |
| June 22, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | A | Restricted Stock Units | 3350 | $0.00 | 3,350.0000 | 24,619,700 | 9999.99% | 0.01% |
| June 16, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | M | Common Stock | 2000 | $0.00 | 2,000.0000 | 24,619,700 | 9999.99% | 0.01% |
| June 16, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Goldberg Andrew D. | Director | M | Restricted Stock Units | 2000 | $0.00 | 0.0000 | 24,619,700 | 100.00% | 0.01% |